| Table |
|---|
Advertisement
Related Companies
Related Deals
- Merck gets ex- N. American rights to Cardiome's oral vernakalant; later gains WW rights; deal ends
- Cardiome enters $68mm anti-arrhythmic deal with Fujisawa; ends
- Astellas to offer $981mm cash for CV Therapeutics; withdrawn
- Lundbeck buys spec pharma Ovation for $600mm plus earn-outs
- Pfizer and GlaxoSmithKline set up HIV joint venture
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IV003298
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
IV003298
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.